Back
Prometheus Biosciences, Inc.
Founded by : Mark McKenna & Scott Glenn, 1 January 2016
San Diego County, United States
More than 250 employees
About the Company
Prometheus Biosciences, Inc. is a pioneering biotechnology company focused on developing precision therapies for the treatment of inflammatory bowel disease (IBD). Founded in 2016 and headquartered in San Diego, California, the company is committed to delivering innovative solutions for patients suffering from these debilitating conditions. Prometheus Biosciences' proprietary platform for precision medicine integrates genomics, big data analytics, and machine learning to identify specific biomarkers and optimize treatment plans for each patient. The company's pipeline includes both small molecule and biological therapies, with several candidates in various stages of clinical development. With a team of experienced scientists, clinicians, and business professionals, Prometheus Biosciences is poised to make a significant impact on the lives of IBD patients worldwide.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Prometheus Biosciences, Inc.’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Biotechnology
- Sub-Industry: Biotechnology
Videos and Photos
Company Address
3050 Science Park Road San Diego, CA 92121 United States
Source : Google maps